Myo-inositol for the Management of Poor Ovarian Responders: A Prospective Randomized Controlled Trial

NCT04273256 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

226

Enrollment

OTHER

Sponsor class

Conditions

Poor Ovarian Response

Interventions

DRUG: Myo-inositol

Sponsor

American University of Beirut Medical Center